Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

SCENAR Therapy in Chronic Non-specific Neck Pain

NCT: NCT07742228 · RECRUITING

NCT IDNCT07742228
StatusRECRUITING
Start Date2026-03-11
Completion2028-07-30
SponsorHopital Foch (OTHER)
First posted
Last updated

Brief Summary

Shifting away from a medication-centered approach is a major public health priority, particularly in chronic pain management, where non-pharmacological therapies are recommended despite barriers such as limited evidence and low prescriber awareness. SCENAR (Self-Controlled Energo-Neuro Adaptive Regulation), an electrotherapy device, lacks robust randomized controlled trial data. A prior study showed effects in both active and placebo groups after a single session, supporting further investigation. This study aims to assess whether repeated SCENAR sessions improve disability, mobility, and pain in patients with chronic neck pain.

Frequently Asked Questions

What is SCENAR Therapy in Chronic Non-specific Neck Pain?

SCENAR Therapy in Chronic Non-specific Neck Pain is a clinical trial registered under NCT07742228. Current status: RECRUITING.

What is the status of NCT07742228?

The current status of NCT07742228 (SCENAR Therapy in Chronic Non-specific Neck Pain) is: RECRUITING.

When did SCENAR Therapy in Chronic Non-specific Neck Pain start?

SCENAR Therapy in Chronic Non-specific Neck Pain started on 2026-03-11.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.